academic article

• Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study..  Ophthalmology.  117:2146-2151. 2010
• Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study..  Ophthalmology.  116:2175-81.e1. 2009